Engaging in discussions with patients at high risk of complications from COVID-19 without seeming patronizing is an important skill that many pharmacists should practice.
Tomasz Jurga, PharmD, BCPS, BCACP
Advertisement
Articles by Tomasz Jurga, PharmD, BCPS, BCACP
Recently, many providers have become worried about the potential of certain medications to worsen transmission and outcomes in the setting of the global COVID-19 pandemic.
Advertisement
Latest Updated Articles
Should Patients Continue Using Cardiovascular Disease Drugs During COVID-19 Pandemic?Published: March 18th 2020 | Updated:
COVID-19: Caring for Patients With Cardiovascular Disease in the Outpatient SettingPublished: May 1st 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
3
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
4
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
5
